Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

REGISTER for free or LOG IN to view this content

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Coronary

Presentation

TCT 2019

CAD Pharma

Up Next

Presentation TCT 2019

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

Presenter: Masato Nakamura

September 28, 2019

More slides +

Presentation TCT 2019

Orbital Atherectomy for Coronary Calcification: When and How

Presenter: Richard Shlofmitz

September 28, 2019

Presentation TCT 2019

Treatment of Severely Calcified Lesions: The Need for Comparative Data

Presenter: Ajay Kirtane

September 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.